Top Healthcare AI Companies in Preventive Heart Health: From AI-powered ECGs and cardiac screening to coronary plaque analysis, wearable monitoring and early vascular-risk detection, these AI healthcare companies are using artificial intelligence to identify cardiovascular risks earlier.
Heart disease does not always announce itself. A person can have high blood pressure, abnormal heart rhythms, coronary plaque or early changes in heart function without experiencing obvious symptoms. That is one reason prevention and early detection have become increasingly important in cardiovascular healthcare.
Artificial intelligence is opening up new ways to analyse ECGs, echocardiograms, CT scans, wearable signals and other health data. Instead of waiting for a heart attack or advanced heart failure, AI-enabled systems can potentially help identify warning signs earlier and support clinicians in deciding who needs further evaluation.
Here are 10 AI companies and healthcare technology innovators working on preventive heart health and earlier cardiovascular risk detection.
1. Tricog Health
When discussing AI and preventive cardiac care in India, Tricog Health is one of the most relevant companies to watch.
Tricog combines AI-powered ECG interpretation with specialist verification and digital cardiac-care workflows.
Its InstaECG platform receives ECG data from healthcare centres, performs preliminary analysis using its AI engine and then routes the ECG for verification by cardiac specialists. The final report can be returned digitally to the healthcare provider within minutes.
This model is particularly important for primary-care centres and locations where a cardiologist may not be immediately available.
In 2026, Tricog also expanded its preventive cardiac-risk proposition through Tricog CardioCheck (TCC). The company partnered with OMRON Healthcare to integrate ECG-enabled blood-pressure monitors with its AI-powered cardiac triage service. According to OMRON, the system can analyse transmitted ECG data and provide a three-level risk assessment in approximately 10 seconds.
What Tricog works on
- AI-assisted ECG interpretation
- Cardiac screening
- Early cardiovascular risk identification
- Remote cardiac diagnosis
- Primary-care cardiac screening
- Heart attack and STEMI pathways
- Digital cardiac-care coordination
Why it matters for prevention
The key opportunity is taking cardiac assessment closer to the patient.
Instead of requiring every person to travel to a tertiary cardiac centre for the first level of assessment, AI-supported ECG systems can help frontline healthcare providers identify patients who may need further cardiac evaluation.
2. Cardiotrack
Cardiotrack is an Indian health-tech company focused strongly on preventive health screening and cardiac assessment.
Its Cardiovisor technology uses AI-powered cardiac diagnostics to provide heart-health insights, while its broader Ethos.AI platform is designed to automate health-screening workflows.
Cardiotrack reports having screened more than 400,000 individuals through a network of more than 1,600 laboratories across 600+ cities.
The company’s preventive-heart programme includes ECG-based assessment and portable stress testing.
Its home-based stress ECG solution is positioned as a preventive cardiac risk-assessment tool, designed to bring cardiac screening outside traditional hospital settings.
What Cardiotrack works on
- AI-powered cardiac screening
- ECG analysis
- Preventive heart assessments
- Portable stress testing
- Home-based cardiac screening
- Health-risk assessment
- Insurance-linked medical screening
Why Cardiotrack matters
One of the biggest opportunities in preventive healthcare is making screening convenient enough that people actually undergo it.
Portable and home-based cardiac testing could potentially help move cardiovascular assessment from hospitals into homes, workplaces and community settings.
3. Agatsa: One of the Top Healthcare AI Companies in Preventive Heart Health
Agatsa is an Indian health-tech company developing portable health-monitoring technologies and AI-powered health insights.
Its ecosystem includes SanketLife, a portable ECG device, along with blood-pressure and metabolic-health monitoring capabilities.
Its newer NERA AI platform is designed to connect information from ECG, metabolic health, sleep, activity, heart-rate variability and stress rather than treating each health measurement as an isolated number.
Agatsa says NERA AI is built on more than 1.5 crore ECG data points and reports 1.3 million+ ECGs analysed, while its platform is designed specifically around preventive rather than reactive healthcare.
What Agatsa works on
- Portable ECG
- Home heart monitoring
- Blood-pressure monitoring
- Metabolic-health tracking
- Heart-rate variability
- Lifestyle monitoring
- AI-powered health insights
Why Agatsa stands out
The interesting shift is from one-time cardiac testing to continuous health intelligence.
Instead of looking only at a single ECG, AI can potentially connect changes in cardiac signals with sleep, activity, metabolic health and lifestyle patterns.
That is much closer to the idea of preventive health.
4. Dozee
Dozee approaches preventive and early-warning cardiac health from a different direction.
Rather than relying on conventional ECG electrodes, the company’s contactless monitoring technology uses ballistocardiography to capture micro-vibrations generated by heartbeats, respiration and body movement.
AI algorithms then convert this information into health biomarkers and risk scores.
Dozee’s hospital platform includes an AI-based early-warning system that analyses vital-sign trends and generates risk scores to help clinicians identify deterioration earlier.
The company currently reports deployment across more than 200 hospitals, along with more than 15,500 life-saving alerts.
What Dozee works on
- Contactless cardiac monitoring
- Heart-rate monitoring
- Respiratory monitoring
- Blood-pressure estimation
- Early-warning systems
- Remote patient monitoring
- Continuous vital-sign analysis
Why Dozee stands out
Preventive heart health isn’t only about finding disease before the first symptom.
It is also about recognising physiological deterioration before a patient becomes critically ill.
Dozee’s continuous-monitoring approach addresses this part of the prevention spectrum.
5. Aarca Research
Aarca Research represents a less conventional but important area of preventive cardiovascular technology: vascular health.
The Bengaluru-linked company has developed its Peripheral Vascular Health (PVH) Program, which uses sensor-based screening and AI to identify early vascular dysfunction.
According to a 2026 NITI Aayog Frontier Tech case study, the system is designed to provide standardised, non-invasive vascular screening outside traditional tertiary-care environments.
This is significant because vascular dysfunction can be associated with cardiovascular and cerebrovascular complications.
The company’s approach aims to identify problems earlier rather than waiting for severe symptoms or complications.
What Aarca Research works on
- Vascular screening
- Peripheral vascular health
- Sensor-based diagnostics
- AI-assisted risk assessment
- Non-invasive screening
- Preventive cardiovascular care
Why it stands out
Most people associate heart prevention with cholesterol, blood pressure and ECGs.
Aarca’s work highlights another important question:
What is happening to the patient’s blood vessels before a major cardiovascular event occurs?
6. Cleerly
US-based Cleerly is taking AI-powered cardiovascular prevention into coronary CT imaging.
Its technology analyses coronary CT angiography (CCTA) and uses AI to create detailed measurements of coronary arteries, including plaque volume, plaque characteristics, stenosis and likely ischemia.
This is important because coronary artery disease can develop silently for years.
Cleerly’s approach is therefore not simply looking for a blockage after symptoms appear. It attempts to characterise the underlying atherosclerotic disease itself.
The company says its platform is based on more than 10 million images from over 40,000 patients and has been evaluated in multicentre clinical studies.
In September 2026, Cleerly announced new ESC Congress data reporting that AI-quantified plaque burden was independently associated with long-term cardiovascular risk.
What Cleerly works on
- Coronary artery disease
- Coronary plaque
- Atherosclerosis
- Stenosis
- Ischemia
- Coronary CT analysis
- Heart-attack risk assessment
Why Cleerly stands out amongst Top AI companies in preventive heart health
Its philosophy is simple:
Don’t wait for the heart attack to discover the disease.
By quantifying plaque earlier, clinicians can potentially better understand a patient’s cardiovascular risk and make more personalised prevention decisions.
7. Ultromics
Ultromics uses AI to analyse echocardiography and identify cardiovascular conditions that can be difficult to recognise early.
Its EchoGo platform includes AI solutions for heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis. The company says its technology can analyse routine echocardiography and provide additional information to support clinical assessment.
Its EchoGo Heart Failure solution is FDA-cleared and was developed with research collaboration involving Mayo Clinic. In clinical evaluation under intended-use conditions, the company reports 90.3% sensitivity and 86.1% specificity for identifying HFpEF.
The company has also positioned AI-based echocardiography as a way to identify heart failure earlier, before symptoms are overlooked or attributed to other causes.
What Ultromics works on
- AI echocardiography
- Heart failure detection
- HFpEF
- Cardiac amyloidosis
- Cardiovascular imaging
- Early cardiovascular disease identification
Why Ultromics stands out
Heart failure can be difficult to identify, particularly in patients whose symptoms are subtle.
AI-assisted echocardiography could potentially help clinicians identify patterns that would otherwise require more complex evaluation.
8. HeartSciences
HeartSciences is focused on another major preventive-health opportunity: extracting more information from a routine ECG.
Its MyoVista platform combines ECG technology with AI-based algorithms designed to identify signs of cardiovascular disease that may not be obvious from conventional ECG interpretation.
Its growing AI-ECG portfolio includes algorithms targeting reduced ejection fraction, preserved ejection fraction, impaired cardiac relaxation and potential valvular disease, among other applications.
In June 2026, HeartSciences launched version 1.3 of MyoVista Insights with an AI-ECG algorithm marketplace, initially incorporating an FDA-cleared algorithm from Bunkerhill Health for detecting reduced left-ventricular ejection fraction from a routine ECG.
The company also has a distribution agreement for India through Mumbai-based MedPhy Technologies.
What HeartSciences works on
- AI-enhanced ECG
- Early heart-disease detection
- Ejection-fraction assessment
- Diastolic dysfunction
- Valvular disease
- Cardiovascular risk identification
Why it matters
ECGs are inexpensive, widely available and relatively quick.
If AI can extract additional clinically useful information from the same test, it could potentially turn a routine ECG into a more powerful screening tool.
9. Cardiologs — Philips
Cardiologs, now part of Philips, applies medical-grade AI to ECG and Holter analysis.
Its platform is designed to automate parts of ECG interpretation, particularly the analysis of long-duration ambulatory recordings.
Philips says Cardiologs’ Holter platform is an FDA-cleared ECG-analysis solution powered by deep learning and has processed more than 200 million ECGs, supporting diagnosis of more than two million patients per year.
The platform can identify multiple types of cardiac events and generate reports that support clinical decision-making.
What Cardiologs works on
- AI ECG analysis
- Holter monitoring
- Arrhythmia detection
- Ambulatory cardiac monitoring
- Automated ECG reporting
- Cardiac rhythm assessment
Why it stands out
Many heart-rhythm problems are intermittent.
A patient may have a normal ECG during a short clinic visit but experience an abnormal rhythm later.
AI-assisted Holter analysis allows clinicians to process much larger volumes of ECG data and potentially identify events that could otherwise be difficult to review manually.
10. Bunkerhill Health
Bunkerhill Health is part of the emerging AI-ECG ecosystem focused on extracting additional cardiovascular information from routine ECG recordings.
Its AI technology has been used to develop algorithms that identify reduced left-ventricular ejection fraction from ECG data.
In 2026, its ECG-EF algorithm became the first FDA-cleared AI-ECG algorithm available through HeartSciences’ MyoVista Insights marketplace.
The broader significance is that AI can potentially use a familiar, low-cost test — the ECG — to identify patients who may need further evaluation such as echocardiography.
What Bunkerhill works on
- AI-ECG
- Ejection-fraction prediction
- Heart failure screening
- Cardiovascular risk identification
- AI-assisted cardiac diagnostics
Why it matters for prevention
A routine ECG is already available in many healthcare settings.
Adding AI could potentially create an additional screening layer without requiring every patient to undergo advanced cardiac imaging immediately.
Also Read: Top AI Companies in Brain Disease Detection
HealthViews Takeaway: Top Healthcare AI Companies in Preventive Heart Health
Preventive heart health is moving beyond the traditional annual check-up.
AI is creating new possibilities for continuous monitoring, smarter ECG interpretation, earlier heart-failure detection, coronary plaque analysis and decentralised cardiovascular screening.
Indian companies such as Tricog, Cardiotrack, Agatsa, Dozee and Aarca Research are contributing to this shift, while global companies such as Cleerly and Ultromics are pushing AI deeper into cardiovascular imaging and disease-risk assessment.
The real promise of this technology is not simply making diagnosis faster.
It is changing the question from:
“What do we do after someone develops heart disease?”
to:
“How early can we identify cardiovascular risk — and what can we do about it?”
That is where AI could have its greatest impact on preventive heart health.
Editorial note: This article ‘Top Healthcare AI Companies in Preventive Heart Health‘ is a curated HealthViews list based on publicly available information about AI technologies, clinical applications, screening capabilities, validation and healthcare deployments. It is not a clinical ranking or medical endorsement. Some companies focus specifically on preventive cardiovascular care, while others provide AI-enabled diagnostic technologies that can contribute to earlier detection.
